Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility

Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility Inhibition of the hERG potassium ion channel by different non-nucleoside human cytomegalovirus polymerase antiviral inhibitor series and the exploration of variations on a pyrroloquinoline core to reduce cardiotoxicity potential The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase Pyrazolopyridines with potent activity against herpesviruses: Effects of C5 substituents on antiviral activity 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as Non-Nucleoside Inhibitors of Human Cytomegalovirus and Related Herpesvirus Polymerases 2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases 7-Aminoquinolines. A novel class of agents active against herpes viruses Cyclic Variations of 3-Quinolinecarboxamides and Effects on Antiherpetic Activity Pyrazolopyrimidines and pyrazolotriazines with potent activity against herpesviruses Structure based molecular design, synthesis and biological evaluation of α-pyrone analogs as anti-HSV agent